XML 62 R51.htm IDEA: XBRL DOCUMENT v3.21.1
Business Segments - Segments in Significant Accounting Policies (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Jun. 30, 2020
Segment Reporting Information          
Net sales $ 211,729 $ 210,739 $ 613,072 $ 614,471  
Depreciation and amortization 7,918 8,248 24,042 24,177  
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 17,782 18,664 50,343 39,131  
Interest expense, net 2,933 3,263 8,957 10,049  
Depreciation and amortization 7,918 8,248 24,042 24,177  
Stock-based compensation     1,129 1,694  
Foreign currency (gains) losses, net (583) (608) (3,590) 1,895  
Identifiable assets 805,017   805,017   $ 784,100
Animal Health          
Segment Reporting Information          
Net sales 134,380 138,974 398,987 404,513  
Mineral Nutrition          
Segment Reporting Information          
Net sales 58,153 56,200 163,750 164,534  
Performance Products          
Segment Reporting Information          
Net sales 19,196 15,565 50,335 45,424  
Operating Segments          
Segment Reporting Information          
Net sales 211,729 210,739 613,072 614,471  
Depreciation and amortization 7,519 7,803 22,802 22,934  
Adjusted EBITDA - Total segments 39,123 40,196 114,043 108,563  
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 17,782 18,664 50,343 39,131  
Interest expense, net 2,933 3,263 8,957 10,049  
Depreciation and amortization 7,519 7,803 22,802 22,934  
Restructuring costs 11,073 10,064 33,162 30,283  
Stock-based compensation   565 1,129 1,694  
Acquisition-related costs of goods sold   0   280  
Acquisition-related transaction costs   0   462  
Acquisition-related other   0   167  
Foreign currency (gains) losses, net (583) (608) (3,590) 1,895  
Adjusted EBITDA - Total segments 39,123 40,196 114,043 108,563  
Identifiable assets 671,518   671,518   657,365
Operating Segments | Animal Health          
Segment Reporting Information          
Net sales 134,380 138,974 398,987 404,513  
Depreciation and amortization 6,457 6,665 19,476 19,760  
Adjusted EBITDA - Total segments 30,962 34,635 94,412 93,534  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 6,457 6,665 19,476 19,760  
Adjusted EBITDA - Total segments 30,962 34,635 94,412 93,534  
Identifiable assets 565,958   565,958   560,663
Operating Segments | Mineral Nutrition          
Segment Reporting Information          
Net sales 58,153 56,200 163,750 164,534  
Depreciation and amortization 646 629 2,042 1,871  
Adjusted EBITDA - Total segments 5,232 4,055 12,464 11,214  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 646 629 2,042 1,871  
Adjusted EBITDA - Total segments 5,232 4,055 12,464 11,214  
Identifiable assets 70,269   70,269   65,686
Operating Segments | Performance Products          
Segment Reporting Information          
Net sales 19,196 15,565 50,335 45,424  
Depreciation and amortization 416 509 1,284 1,303  
Adjusted EBITDA - Total segments 2,929 1,506 7,167 3,815  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 416 509 1,284 1,303  
Adjusted EBITDA - Total segments 2,929 1,506 7,167 3,815  
Identifiable assets 35,291   35,291   31,016
Corporate          
Segment Reporting Information          
Depreciation and amortization 399 445 1,240 1,243  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 399 445 1,240 1,243  
Corporate costs   $ 0   $ 425  
Identifiable assets $ 133,499   $ 133,499   $ 126,735